Sandbox: HS: Difference between revisions

Jump to navigation Jump to search
Husnain Shaukat (talk | contribs)
Husnain Shaukat (talk | contribs)
Line 674: Line 674:
|}
|}
|}
|}
==Classification==
Acute liver failure may be classified on the basis of the duration of the [[symptoms]] between the onset of [[jaundice]] to the onset of [[encephalopathy]]. The different classification systems based on the number of weeks from the appearance of jaundice to the encephalopathy are:
{| class="wikitable"
! Classification system!! Duration
|-
| O’Grady System||
* Hyperacute  (0 - 1 week)
* Acute            ( From  2nd week - 4 weeks)
* Subacute      ( From 4th week - 12 weeks)
|-
| Bernuau System||
* Fulminant      ( 0 - 2 weeks) 
* Subfulminant  ( 2 weeks - 12 weeks)
|-
|Japanese System ||
* Fulminant      (0 - 8 weeks)
** Acute      ( 0 - 1.5 weeks)
** Subacute ( 1.5 weeks - 8 weeks)
* Late-Onset    ( 8 weeks - 12 weeks)
|}
The 1993 classification defines three subcategories based on the severity and duration of the acute liver failure. <ref>O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. ''[[The Lancet|Lancet]] 1993;342:273-5. PMID 8101303.''</ref> The importance of this method of classification is that the pace of the disease evolution strongly influences prognosis. The underlying [[etiology]] causing the development of acute liver failure is the other significant determinant in regards to prognosis.<ref name="ogredy1">{{cite journal |author=O'Grady JG |title=Acute liver failure |journal=Postgraduate medical journal |volume=81 |issue=953 |pages=148-54 |year=2005 |pmid=15749789 |doi=10.1136/pgmj.2004.026005}}</ref> This classification system is based upon the duration between onset of [[jaundice]] to onset of [[encephalopathy]].
{| class="wikitable"
! Classification!! Time
|-
| Hyperacute|| 1 week
|-
| Acute|| 1 week - 1 month
|-
|Subacute || 1 week - 3 months
|}
Acute liver failure can also be classified into fulminant or subfulminant. Both of these forms have a poor prognosis. It is based upon the duration between onset of hepatic illness, to the development of encephalopathy.<ref name="pmid9027947">{{cite journal |author=Williams R |title=Classification, etiology, and considerations of outcome in acute liver failure |journal=[[Seminars in Liver Disease]] |volume=16 |issue=4 |pages=343–8 |year=1996 |month=November |pmid=9027947 |doi=10.1055/s-2007-1007247 |url=http://www.thieme-connect.com/DOI/DOI?10.1055/s-2007-1007247 |accessdate=2012-10-26}}</ref>
{| class="wikitable"
! Classification !! Time
|-
|Fulminant  || within 2 months
|-
|Subfulminant || within 2 months to 6 months
|}
===O’Grady System===
The classification of encephalopathy according to the O’Grady system is as follows.<ref name="O'Grady-1993">{{Cite journal  | last1 = O'Grady | first1 = JG. | last2 = Schalm | first2 = SW. | last3 = Williams | first3 = R. | title = Acute liver failure: redefining the syndromes. | journal = Lancet | volume = 342 | issue = 8866 | pages = 273-5 | month = Jul | year = 1993 | doi =  | PMID = 8101303 }}</ref>
====Hyperacute====
Hyperacute encephalopathy is an encephalopathy that occurs within 7 days of onset of jaundice.
====Acute====
Acute encephalopathy is an encephalopathy that occurs within an interval of 8 to 28 days from onset of jaundice.
====Subacute====
Subacute encephalopathy is an encephalopathy that occurs within 5 to 12 weeks of onset of jaundice.
===Bernuau System===
The classification of encephalopathy according to the Bernuau system is as follows.<ref name="Bernuau-1986">{{Cite journal  | last1 = Bernuau | first1 = J. | last2 = Rueff | first2 = B. | last3 = Benhamou | first3 = JP. | title = Fulminant and subfulminant liver failure: definitions and causes. | journal = Semin Liver Dis | volume = 6 | issue = 2 | pages = 97-106 | month = May | year = 1986 | doi = 10.1055/s-2008-1040593 | PMID = 3529410 }}</ref>
====Fulminant====
Fulminant encephalopathy is an encephalopathy that occurs within 2 weeks of onset of jaundice.
====Subfulminant====
Subfulminant encephalopathy is an encephalopathy that occurs within an interval of 2 to 12 weeks from onset of jaundice.
====Japanese System====
The classification of encephalopathy according to the Bernuau system is as follows.<ref name="Mochida-2008">{{Cite journal  | last1 = Mochida | first1 = S. | last2 = Nakayama | first2 = N. | last3 = Matsui | first3 = A. | last4 = Nagoshi | first4 = S. | last5 = Fujiwara | first5 = K. | title = Re-evaluation of the Guideline published by the Acute Liver Failure Study Group of Japan in 1996 to determine the indications of liver transplantation in patients with fulminant hepatitis. | journal = Hepatol Res | volume = 38 | issue = 10 | pages = 970-9 | month = Oct | year = 2008 | doi = 10.1111/j.1872-034X.2008.00368.x | PMID = 18462374 }}</ref>
====Fulminant====
Fulminant encephalopathy is an encephalopathy that occurs within 8 weeks of onset of jaundice.
====Late-Onset====
Late onset encephalopathy is an encephalopathy that occurs within an interval of 8 to 24 weeks from onset of jaundice.
====Acute====
Acute encephalopathy is an encephalopathy that occurs within 10 days of onset of jaundice
====Subacute====
Subacute encephalopathy is an encephalopathy that occurs within an interval of 11 to 56 days from onset of jaundice
<references />

Revision as of 15:34, 13 February 2018


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Differential diagnosis

Abbreviations: COPD= Chronic obstructive pulmonary disease,

Causes of cyanosis Disease Cyanosis Clinical manifestations/association Diagnosis Additional

findings

Symptoms Signs
Peripheral Central Dyspnea Fever Chest pain Clubbing Peripheral edema Auscultation Lab Findings Imaging Gold standard
Respiratory Airway

disorder

Croup + +
Epiglottitis +
Foreign body aspiration + +
Airway trauma + + ±
Disease Peripheral Central Dyspnea Fever Chest pain Clubbing Peripheral edema Auscultation Lab Findings Imaging Gold standard Additional findings
Parenchymal

disorder

Pulmonary embolism
  • ABGs
  • D-dimer
  • Dyspnea
  • Tachycardia
  • Pleuretic chest pain
Pneumonia
  • ABGs
  • Leukocytosis
  • Pancytopenia
  • CXR
  • CT chest
  • Bronchoscopy
  • Shortness of breath
  • Cough
Asthma

(Late)

+
Cystic fibrosis ± ±
COPD

(Emphysema)

± +
Empyema ± + Chest X-ray
  • Pleural opacity
  • Localization of effusion
Physical examination
Disease Peripheral Central Dyspnea Fever Chest pain Clubbing Peripheral edema Auscultation Lab Findings Imaging Gold standard Additional findings
Chest

wall

disorders

Flail chest ±
Pneumothorax ±
Hemothorax + ±
Cardiovascular Congenital

heart diseases

Disease Peripheral Central Dyspnea Fever Chest pain Clubbing Peripheral edema Auscultation Lab Findings Imaging Gold standard Additional findings

Atrioventricular canal defect

+ +
Ebstein anomaly
Hypoplastic left heart syndrome
Pulmonary atresia
Tetralogy of Fallot
Pulmonic stenosis
Total anomalous pulmonary venous drainage
Transposition of the great vessels
Truncus arteriosus
Disease Peripheral Central Dyspnea Fever Chest pain Clubbing Peripheral edema Auscultation Lab Findings Imaging Gold standard Additional findings
Heart failure + + ± +
Valvular heart disease +
Myocardial infarction
Hematologic Methemoglobinemia
Polycythemia
Central Nervous system Peripheral Central Dyspnea Fever Chest pain Clubbing Peripheral edema Auscultation Lab Findings Imaging Gold standard Additional findings
Coma
Seizures
Head trauma
Breath holding spells
Miscellaneous Shock
Smoke inhalation + + +
Toxic gases + + + + ±
Cold exposure
  • Fingerstick glucose (Hyperglycemia)
  • Electrocardiogram (ECG) may show J wave, sinus bradycardia and prolongation of all ECG intervals.
  • Serum electrolytes (including potassium and calcium)
  • BUN and creatinine
  • Serum hemoglobin, white blood cell, and platelet counts ( Raised HCT due to volume contraction)
  • Coagulation profile (clotting factors impairment)
  • Serum lactate ( lactic acidosis)
  • Creatine kinase (Rhabdomylosis)
  • Arterial blood gas
  • CXR
* Mild hypothermia: core temperature 32 to 35°C ; patient presents with confusion, tachycardia, and increased shivering.
  • Moderate hypothermia: 28 to 32°C patient presents with lethargy, bradycardia and arrhythmia and decreased shivering.
  • Severe hypothermia: below 28°C patient presents with coma, hypotension, arrhythmia, pulmonary edema, and rigidity.
Drugs†